AZN vs BHM · P/E 28, $288.38B cap vs rev $68.7M
AstraZeneca PLC (AZN) versus Bluerock Homes Trust Inc. (BHM) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Bluerock Homes Trust Inc. (BHM) is a reit - residential company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported BHM revenue for 2025-12-31 was $68.7M. Net income was -$32.6M. Revenue was up 36.9% from 2024-12-31 to 2025-12-31. BHM currently screens at market cap $40.1M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. BHM currently screens at market cap $40.1M.
Not investment advice. Open the AZN and BHM stock pages for the full models.
Not investment advice.